Treatment of Metastatic Renal Cell Carcinoma With Autologous T-Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX: First Clinical Experience

This publication has 8 references indexed in Scilit:

• Parallel Detection of Transduced T Lymphocytes After Immunogene Therapy of Renal Cell Cancer by Flow Cytometry and Real-Time Polymerase Chain Reaction: Implications for Loss of Transgene Expression
  Human Gene Therapy, 2005
• Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer
  Cancer Gene Therapy, 2005
• Lack of Efficacy of Two Consecutive Treatments of Radioimmunotherapy With ¹³¹I-cG250 in Patients With Metastasized Clear Cell Renal Cell Carcinoma
  Journal of Clinical Oncology, 2005
• Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
  Journal of Clinical Oncology, 2005
• Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
  Proceedings of the National Academy of Sciences, 2004
• A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
  British Journal of Cancer, 2004
• Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer
  Cancer Gene Therapy, 2002
• Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity.
  The Journal of Immunology, 1996